THE ADECCO GROUP APPOINTS NEW HEAD OF INVESTOR RELATIONS & PORTFOLIO STRATEGY
Diego has a strong track record in both capital markets and corporate strategy. Since joining the Adecco Group in
Diego reports to Valentina Ficaio, Group Chief Financial Officer, based in
Valentina Ficaio, Group CFO, said: "I am very much looking forward to the collaboration with Diego. He brings valuable investor relations experience and has been instrumental in driving our acquisition and divestiture pipeline with clarity to leverage new market opportunities and manage our portfolio.
"I would like to thank Benita for her valuable contributions to our investor relations function in the last years and wish her every success in her future endeavors."
About The Adecco Group
The Adecco Group is the world's leading talent and technology expertise company. Our purpose is making the future work for everyone. Through our three global business units - Adecco, Akkodis and LHH - across 60 countries, we enable sustainable and lifelong employability for individuals, deliver digital and engineering solutions to power the Smart Industry transformation and empower organizations to optimize their workforces. The Adecco Group leads by example and is committed to fostering sustainable employability and supporting resilient economies and communities. The Adecco Group AG is headquartered in Zurich, Switzerland (ISIN: CH0012138605) and listed on the SIX Swiss Exchange (ADEN).
For further information, please contact:
Investor Relations +41 (0)44 878 88 88 | Press Office +41 (0) 79 876 09 21 |
View original content to download multimedia:https://www.prnewswire.com/news-releases/the-adecco-group-appoints-new-head-of-investor-relations--portfolio-strategy-302810966.html
SOURCE The Adecco Group
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Actinium Pharmaceuticals Announces Actimab-A Intellectual Property and Manufacturing Advances and Provides NYSE American Listing Update
- Medicure Reports Financial Results for Quarter Ended June 30, 2026 and Schedules August 17, 2026 Conference Call
- Appili Therapeutics Reports Financial and Operational Results for First Quarter of Fiscal Year 2027
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
Definitive AgreementSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share